Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus SODIUM CHLORIDE 0 9 AND POTASSIUM CHLORIDE 0 075 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus SODIUM CHLORIDE 0 9 AND POTASSIUM CHLORIDE 0 075 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN PLASTIC CONTAINER vs SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate causes decreased release of acetylcholine at the neuromuscular junction, reducing muscle contractility. It also blocks calcium channels, leading to vasodilation and anticonvulsant effects.
Sodium chloride 0.9% and potassium chloride 0.075% solution provides electrolyte replacement to maintain fluid and electrolyte balance. Sodium is the principal cation of extracellular fluid and maintains osmotic pressure and acid-base balance. Potassium is the principal intracellular cation and is essential for nerve impulse transmission, muscle contraction, and enzymatic reactions.
IV: 1-4 g as a 10-20% solution, rate not exceeding 1 g/min; for eclampsia: 4-5 g IV bolus then 1-2 g/hour IV infusion.
Intravenous infusion: 500-1000 mL as a single dose; rate determined by clinical needs, typically 2-4 mL/min. Maximum infusion rate 20 mEq K+/hour.
None Documented
None Documented
Normal renal function: 4–6 hours (terminal). In oliguria or anuria, half-life may extend to >24 hours, requiring dose adjustment.
Sodium and potassium ions have distribution half-lives of ~20-30 minutes; elimination half-life is not applicable as they are freely filtered and reabsorbed to maintain homeostasis. Clinical context: Kinetics depend on renal function and hydration status.
Primarily renal (glomerular filtration); >90% excreted unchanged in urine. Biliary/fecal elimination is negligible (<1%).
Renal: >95% of infused sodium and potassium ions are excreted unchanged in urine. Fecal and biliary routes are negligible (<5%).
Category C
Category A/B
Electrolyte
Electrolyte